| 000 | 01624 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513043537.0 | ||
| 264 | 0 | _c19950727 | |
| 008 | 199507s 0 0 eng d | ||
| 022 | _a1066-5099 | ||
| 024 | 7 |
_a10.1002/stem.5530130203 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHurtado, R | |
| 245 | 0 | 0 |
_arHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia. _h[electronic resource] |
| 260 |
_bStem cells (Dayton, Ohio) _cMar 1995 |
||
| 300 |
_a112-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadverse effects |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aLeukemia-Lymphoma, Adult T-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 700 | 1 | _aCandelaria, M | |
| 700 | 1 | _aVargas, F | |
| 700 | 1 | _aMajluf, A | |
| 700 | 1 | _aBolaños, F | |
| 700 | 1 | _aLabardini, J R | |
| 773 | 0 |
_tStem cells (Dayton, Ohio) _gvol. 13 _gno. 2 _gp. 112-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/stem.5530130203 _zAvailable from publisher's website |
| 999 |
_c7787138 _d7787138 |
||